In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Abstract

MicroRNAs (miRNAs), small non-coding RNAs, can regulate post-transcriptional gene expressions and silence a broad set of target genes. miRNAs, aberrantly expressed in cancer cells, play an important role in modulating gene expressions, thereby regulating downstream signaling pathways and affecting cancer formation and progression. Oncogenes or tumor suppressor genes regulated by miRNAs mediate cell cycle progression, metabolism, cell death, angiogenesis, metastasis and immunosuppression in cancer. Recently, miRNAs have emerged as therapeutic targets or tools and biomarkers for diagnosis and therapy monitoring in cancer. Since miRNAs can regulate multiple cancer-related genes simultaneously, using miRNAs as a therapeutic approach plays an important role in cancer therapy. However, one of the major challenges of miRNA-based cancer therapy is to achieve specific, efficient and safe systemic delivery of therapeutic miRNAs in vivo. This review discusses the key challenges to the development of the carriers for miRNA-based therapy and explores current strategies to systemically deliver miRNAs to cancer without induction of toxicity.

• Authors: Yunching Chen, Dong-Yu Gao, Leaf Huang
• Journal: Advanced drug delivery reviews (Adv Drug Deliv Rev) Vol. 81 Pg. 128-41 (Jan 2015) ISSN: 1872-8294 [Electronic] Netherlands
• PMID: 24859533 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2014 Elsevier B.V. All rights reserved.

Chemical References

• MicroRNAs

Topics

• Animals
• Disease Progression
• Gene Expression Regulation, Neoplastic
• Gene Silencing
• Gene Transfer Techniques
• Humans
• MicroRNAs (administration & dosage, genetics)
• Neoplasms (genetics, therapy)
• RNA Processing, Post-Transcriptional (genetics)
• Signal Transduction (genetics)